US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

295.76

-35.4700-10.71%

Post-market: 295.760.00000.00%19:55 EDT

Volume:530.48K

Turnover:162.52M

Market Cap:583.97M

PE:- -

High:323.00

Open:322.79

Low:294.70

Close:331.23

52wk High:341.93

52wk Low:68.00

Shares:1.97M

Float Shares:1.97M

Volume Ratio:1.45

T/O Rate:26.87%

Dividend:1.03

Dividend Rate:0.35%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Chemed unit claimed to misdiagnose dementia patients, Capitol Forum says

Sector Update: Healthcare

MT Newswires Live

Sigma Healthcare (ASX:SIG) Shares Drift As Margin Compression Tempers Profit Growth

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)

Healthcare Exec Lists $18.25 Million French Chateau-Style Home Outside Atlanta

Sector Update: Healthcare

MT Newswires Live

Codexis to Participate in Cantor Global Healthcare Conference 2026

SL Science Files FDA Drug Master File for GDT Cell-Derived Exosomes

MT Newswires Live

Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference

Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor

Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Immuneering (IMRX)

Hygeia Healthcare Lifts Profit, Boosts Cash Flow and Unveils Expanded Shareholder Return Plan

Analysts Have Conflicting Sentiments on These Healthcare Companies: NeoGenomics (NEO) and Medtronic (MDT)

Hygeia Healthcare to Present 2026 Interim Results via Investor Call

IHH Healthcare's Attributable Profit Jumps 29% in Q2

MT Newswires Live

Jazz Pharmaceuticals (JAZZ) Stock May Be Undervalued As FDA Cancer Approval Lands

Simply Wall St.

Revolution Medicines: Buy Rating Reiterated as FDA Approval and Strong Prelaunch Demand Support Unchanged $225 Price Target

Health Care Roundup: Market Talk

FDA Grants First Broad RAS Inhibitor Approval for Advanced Pancreatic Cancer, Cutting Mortality by 60% in Second-Line Setting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/LABU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":295.76,"timestamp":1787947200000,"preClose":331.23,"halted":0,"volume":530479,"hourTrading":{"tag":"盘后","latestPrice":295.76,"preClose":295.76,"latestTime":"19:55 EDT","volume":2719,"amount":805526.7898,"timestamp":1787961358839,"change":0,"changeRate":0,"amplitude":0.003466},"delay":0,"changeRate":-0.10708571083537127,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Market Closed","change":-35.47,"latestTime":"08-28 16:00:00 EDT","open":322.785,"high":323,"low":294.7,"amount":162523074.03118002,"amplitude":0.085439,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":331.23,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.003472,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":323.7,"preClose":331.23,"latestTime":"09:29 EDT","volume":2163,"amount":708605.00781,"timestamp":1787923795309,"change":-7.53,"changeRate":-0.022733,"amplitude":0.034055},"postHourTrading":{"tag":"盘后","latestPrice":295.76,"preClose":295.76,"latestTime":"19:55 EDT","volume":2719,"amount":805526.7898,"timestamp":1787961358839,"change":0,"changeRate":0,"amplitude":0.003466},"volumeRatio":1.445542973311124,"impliedVol":0.9101,"impliedVolPercentile":0.5259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.445542973311124,"shares":1974486,"dividePrice":1.0268,"high":323,"amplitude":0.085439,"preClose":331.23,"low":294.7,"week52Low":68,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":295.76,"eps":0,"divideRate":0.003472,"volume":530479,"delay":0,"ttmEps":0,"open":322.785,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":317.2,"twentyDayClose":227.4,"sixtyDayClose":165.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662111082","title":"Chemed unit claimed to misdiagnose dementia patients, Capitol Forum says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662111082","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662111082?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:35","pubTimestamp":1787852110,"startTime":"0","endTime":"0","summary":"The Capitol Forum stated in a post to X: “Chemed (CHE): Vitas Healthcare Misdiagnosed Dementia Patients and ‘Fudged’ Evaluation Scores in Order to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/chemed-unit-claimed-to-misdiagnose-dementia-patients-capitol-forum-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/chemed-unit-claimed-to-misdiagnose-dementia-patients-capitol-forum-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","IE00BLDYK493.USD","BK4179","LU1620156130.USD","LU1596574779.USD","CHE","LU2413666004.HKD","BK4588","LU1721427968.SGD","XBI","LU1620156213.USD","LU1543694498.USD","SOCL","LABU","FET","LU1165135440.EUR","XLV","BK4581","BK4585","LU2413665964.HKD","IE00B64QTZ34.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662017084","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662017084","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662017084?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:03","pubTimestamp":1787850204,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF  shedding 0.7%.The iShares Biotechnology ETF  was fractionally lower.In corporate news, Moderna  shares fell 5.6% after it said Thursday it plans to offer $2 billion worth of convertible senior notes due 2032 in a private placement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MRNA","BK4551","GNOM","BK4585","MRNY","LGHT","BK4581","LU0128526141.USD","BK4532","BK4501","BK4548","LABU","FDN","BK4139","BK4588","BK4533","BK4137","STT","MRNX","XBI","BK4568","LU0029874061.USD","HCSG","XLV","BK4534","IBB","IDNA","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662808465","title":"Sigma Healthcare (ASX:SIG) Shares Drift As Margin Compression Tempers Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662808465","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662808465?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:40","pubTimestamp":1787845258,"startTime":"0","endTime":"0","summary":"Sigma Healthcare stock closed at A$2.62, with the shares drifting over the past month even as the company posted one of the stronger profit stories in Australian healthcare retail this season. The headline is simple: normalised net profit after tax reached A$732 million and normalised earnings per share came in at A$0.064, backed by a A$0.04 full year dividend.\nThe short term price softness now sits against a business that has lifted earnings faster than revenue and is running a trailing net...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-sig/sigma-healthcare-shares/news/sigma-healthcare-asxsig-shares-drift-as-margin-compression-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-sig/sigma-healthcare-shares/news/sigma-healthcare-asxsig-shares-drift-as-margin-compression-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","BK7103","SIG.AU","XLV","XBI","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662813780","title":"Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662813780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662813780?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:20","pubTimestamp":1787844046,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Verrica Pharmaceuticals (VRCA) and Amgen (AMGN). Verrica Pharmace...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","LU0109394709.USD","TBXU","IE0009355771.USD","VRCA","BK4139","BK4007","LU2089984988.USD","IE00BJT1NW94.SGD","PBE","LU2242646821.SGD","IBBQ","LU0868494617.USD","LU1057294990.SGD","LU0289739699.SGD","LU0889565916.HKD","BIB","BK4599","HCSG","BK4137","IE0002141913.USD","BK4566","IE00B4R5TH58.HKD","BK4581","LU2242652126.USD","LU2112291526.USD","IE00B2B36J28.USD","LU0128526141.USD","LU1061106388.HKD","LU0122379950.USD","BK4534","PJP","IE00BFTCPJ56.SGD","BK4533","BBH","AMGN","IE00BJJMRZ35.SGD","XBI","IBB","LU1571399168.USD","LU0029874061.USD","LU0058720904.USD","SG9999001440.SGD","XLV","LU0320765992.SGD","LU1983299246.USD","BK4585","LU2468319806.SGD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662304088","title":"Healthcare Exec Lists $18.25 Million French Chateau-Style Home Outside Atlanta","url":"https://stock-news.laohu8.com/highlight/detail?id=2662304088","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662304088?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:11","pubTimestamp":1787836260,"startTime":"0","endTime":"0","summary":"For her 6th birthday party, Anna Windley had pony rides and a petting zoo at her parents' French chateau-style house outside Atlanta. Inside there was a playroom for Anna and her sister, Ava, complete","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","LU0128526141.USD","BK4195","XLV","BK4581","LU0029874061.USD","BK4585","BK4588","XBI","HBCP","BK4137","HCSG","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662007177","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662007177","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662007177?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:01","pubTimestamp":1787835662,"startTime":"0","endTime":"0","summary":"Healthcare stocks were declining pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF  0.7% lower and the iShares Biotechnology ETF  down 0.5%.Novo Nordisk  said China's National Medical Products Administration has accepted its marketing application for the oral version of its weight-loss drug Wegovy, Reuters reported. Novo Nordisk stock was down more than 2% premarket.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4599","NVOX","LU1093756168.USD","IBB","XBI","IE00BKVL7J92.USD","BK4007","LU0154236417.USD","BK4588","LABU","PPH","BK4581","NVO","BK4585","THNR","XLV","IE00BZ1G4Q59.USD","OZEM","NVOC","NVOH","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662851820","title":"Codexis to Participate in Cantor Global Healthcare Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662851820","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662851820?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:00","pubTimestamp":1787835600,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., Aug.  27, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352067/24825/en/codexis-to-participate-in-cantor-global-healthcare-conference-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EES","XLV","BK4137","XBI","BK4588","LU0029874061.USD","BK4121","CDXS","BK4585","BK4581","HCSG","LU0128526141.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662755707","title":"SL Science Files FDA Drug Master File for GDT Cell-Derived Exosomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662755707","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662755707?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:41","pubTimestamp":1787834466,"startTime":"0","endTime":"0","summary":"SL Science  said Thursday that its licensor, JY BioMed, filed a new drug master file with the US Food and Drug Administration covering exosomes derived from Gamma Delta T, or GDT, cells.The company said the filing, numbered 044612, adds manufacturing and quality documentation for the cell-free exosome format of the GDT technology, potentially streamlining regulatory work for future programs.SL Science said the exosomes could have potential applications in oncology, including brain cancer, as preclinical research suggests they can trigger tumor cell death, stimulate immune responses and cross the blood-brain barrier.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4139","SLBT","LABU","GDT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662856680","title":"Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662856680","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662856680?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:05","pubTimestamp":1787832300,"startTime":"0","endTime":"0","summary":"PLYMOUTH MEETING, Pa., Aug.  27, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the 2","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3351980/0/en/harmony-biosciences-to-participate-in-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BK4585","LU0128526141.USD","BK4588","BK4581","HCSG","XLV","XBI","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662859610","title":"Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2662859610","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662859610?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:00","pubTimestamp":1787832000,"startTime":"0","endTime":"0","summary":"HAIFA, Israel, Aug.  27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri”), a biotechnology company, leveraging its proprietary three-dimensional (\"3D\") cell expansion platform","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3351959/11974/en/pluri-announces-pricing-of-3-3-million-registered-direct-offering-and-concurrent-private-placement-with-a-single-healthcare-focused-institutional-investor.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","XBI","XLV","HCSG","BK4585","BK4581","BK4139","BK4137","CDMO","LU0128526141.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662163701","title":"Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662163701","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662163701?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:50","pubTimestamp":1787827800,"startTime":"0","endTime":"0","summary":"DEER PARK, Ill., Aug.  27, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3351865/0/en/eton-pharmaceuticals-to-participate-at-2026-wells-fargo-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","LU0149725797.USD","LU0130517989.USD","BK4137","LU0106831901.USD","LU0310799852.SGD","LU1894683348.USD","LABU","TFNS","LU2461242641.AUD","KBWB","LU0708994859.HKD","LU0162691827.USD","BK4585","LU0029864427.USD","LU1280957306.USD","XLV","LU2361045086.USD","IE00B19Z3581.USD","LU0289960550.SGD","LU0971096721.USD","IYF","LU0267386448.USD","BK4207","FTXO","LU1069347547.HKD","LU0787776722.HKD","LU0211328371.USD","LU0310800379.SGD","BK4582","LU1814569148.SGD","HCSG","PGF","LU2361044949.HKD","XBI","LU0128526141.USD","LU0072461881.USD","LU0417517546.SGD","LU1035773651.USD","LU0868494708.USD","LU0175139822.USD","LU0683600562.USD","LU0251131958.USD","LU0742534661.SGD","LU1894683264.USD","LU0128525929.USD","LU0256863811.USD","LU1074936037.SGD","LU1267930227.SGD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706801","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Immuneering (IMRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706801","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706801?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:30","pubTimestamp":1787826622,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Immuneering (IMRX) w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-immuneering-imrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-immuneering-imrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD","HCSG","IE00BJT1NW94.SGD","BK4581","IE00B2B36J28.USD","BK4137","BK4539","LU0128526141.USD","IE0009354923.USD","XBI","XLV","IE0002141913.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","BK4563","BK4588","LABU","LU0029874061.USD","CANC","BK4139","IE0009355771.USD","LU0109394709.USD","IE00B4R5TH58.HKD","PTH","IE00BFTCPJ56.SGD","BK4585","IDNA","LU0889565916.HKD","IMRX","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703205","title":"Hygeia Healthcare Lifts Profit, Boosts Cash Flow and Unveils Expanded Shareholder Return Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703205?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:10","pubTimestamp":1787825420,"startTime":"0","endTime":"0","summary":"An announcement from Hygeia Healthcare Holdings Co., Ltd. ( ($HK:6078) ) is now available. Hygeia Healthcare reported interim revenue of RMB1,961.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-lifts-profit-boosts-cash-flow-and-unveils-expanded-shareholder-return-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-lifts-profit-boosts-cash-flow-and-unveils-expanded-shareholder-return-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4585","LU0128526141.USD","LU0029874061.USD","LABU","XBI","BK4581","XLV","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703720","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: NeoGenomics (NEO) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703720","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703720?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:10","pubTimestamp":1787825408,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NeoGenomics (NEO) and Medtronic (MDT). NeoGenomics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-neogenomics-neo-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-neogenomics-neo-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU1116320737.USD","LU1244550577.SGD","IE00BQXX3F31.USD","IE00BVYPNW00.USD","LU0162691827.USD","IE000M9KFDE8.USD","LU0012050646.USD","XBI","BK4566","LU0265550359.USD","LU2089283258.USD","LU0158827781.USD","BK4581","IE00BGHQF631.EUR","LU0029874061.USD","LU0211331839.USD","BK4196","IE00B3PB1722.GBP","LU0006306889.USD","NEO","HCSG","IE00B42XCP33.USD","LU0072461881.USD","LU1116320901.HKD","LU1244550494.USD","LU0211326839.USD","LU1989764748.USD","FBT","LU2028103732.USD","LU0208291251.USD","BK4137","BK4585","MDT","LU2089984988.USD","LU0432979614.USD","LU2023251221.USD","LU0128526141.USD","LU1989771016.USD","LU1291159041.SGD","IE00BFXG1179.USD","LU0496365809.HKD","XLV","LU1571399168.USD","LU0106261372.USD","LU1983299246.USD","IE00BVYPNV92.GBP","LU1506573853.SGD","LU1989764664.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662213703","title":"Hygeia Healthcare to Present 2026 Interim Results via Investor Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2662213703","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662213703?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:09","pubTimestamp":1787825368,"startTime":"0","endTime":"0","summary":"Hygeia Healthcare Holdings Co., Ltd. ( ($HK:6078) ) just unveiled an update. Hygeia Healthcare Holdings Co., Ltd. has announced it will host a conf...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-to-present-2026-interim-results-via-investor-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-to-present-2026-interim-results-via-investor-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0029874061.USD","HCSG","LU0128526141.USD","BK4581","BK4585","BK4137","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662770481","title":"IHH Healthcare's Attributable Profit Jumps 29% in Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=2662770481","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662770481?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:46","pubTimestamp":1787824019,"startTime":"0","endTime":"0","summary":"IHH Healthcare's  attributable profit to owners jumped 29% during the second quarter of the year to 573 million ringgit from 443 million ringgit a year earlier, according to a Thursday filing with the Malaysian Exchange.Earnings per share came in at 0.0648 ringgit compared with 0.0502 ringgit in the year-ago period.Revenue rose 12% year over year to 7.05 billion ringgit from 6.3 billion ringgit.The healthcare services provider declared an interim dividend of 0.055 ringgit per share for the period, payable by Oct. 30.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK6092","BK4585","BK4137","LU0128526141.USD","BK6511","LU0029874061.USD","BK4588","LABU","Q0F.SI","XLV","XBI","HCSG","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703987","title":"Jazz Pharmaceuticals (JAZZ) Stock May Be Undervalued As FDA Cancer Approval Lands","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703987","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703987?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:22","pubTimestamp":1787822560,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals has doubled in the past year, yet the valuation checks send a more muted signal, with the stock screening as undervalued on earnings multiples but only showing a mixed overall value score. For investors, the question now is whether the recent rally has already captured much of the good news around the company.\n\nOver the past 12 months, Jazz Pharmaceuticals has delivered a return of about 100%, which puts the recent share price near the upper end of its one year range and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/jazz-pharmaceuticals-jazz-stock-may-be-undervalued-as-fda-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/jazz-pharmaceuticals-jazz-stock-may-be-undervalued-as-fda-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0889565916.HKD","BK4532","IE00BN0W2V16.EUR","VGFPF","FEBU","LABU","BK4585","JOYT","LU0154245673.USD","DECU","VOTE","JAZZ","BK4007","RGLO","GXDW","IE00BN0W2T93.GBP","LU0154245756.USD","LU0320765992.SGD","PMDE","LU0823416689.USD","BK4588","BK4533","IE00BN0W2W23.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745297","title":"Revolution Medicines: Buy Rating Reiterated as FDA Approval and Strong Prelaunch Demand Support Unchanged $225 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745297","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745297?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:35","pubTimestamp":1787819736,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Alec Stranahan has maintained their bullish stance on RVMD stock, giving a Buy rating yesterday. Alec Stranahan ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/revolution-medicines-buy-rating-reiterated-as-fda-approval-and-strong-prelaunch-demand-support-unchanged-225-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/revolution-medicines-buy-rating-reiterated-as-fda-approval-and-strong-prelaunch-demand-support-unchanged-225-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771196","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771196","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771196?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:20","pubTimestamp":1787818800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0721 GMT - Novo Nordisk faces persistent concerns over the scope","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0955669360.SGD","LU0165289439.USD","LU0823038988.USD","LU0048597586.USD","LU0672654166.SGD","LU2238330802.EUR","LU0011963245.USD","LU0211331839.USD","SG9999001903.USD","SG9999000343.SGD","LU0315178854.USD","LU1282649810.SGD","LU0210637038.USD","SG9999009443.AUD","LU1211504680.USD","LU0823413587.USD","BK6523","LU0886674414.USD","LU0588545490.SGD","LU1282649067.USD","SG9999003826.SGD","LU1634259391.SGD","BK6112","BK4588","BK6516","LU0823413660.USD","LU1497733631.SGD","SG9999004220.SGD","XBI","LU0762540952.USD","LU0823417737.USD","LU0577902454.USD","D05.SI","LU0648948544.HKD","LU2152927971.USD","LU0061477393.USD","SG9999000475.SGD","SGXZ58947870.SGD","XLV","LABU","LU0873338254.USD","SG9999003800.SGD","SG9999004360.SGD","LU0878005551.USD","LU0823417653.USD","SG9999005177.SGD","SG9999008742.SGD","LU0326948709.USD","LU0543330483.HKD","LU0577902538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164145033","title":"FDA Grants First Broad RAS Inhibitor Approval for Advanced Pancreatic Cancer, Cutting Mortality by 60% in Second-Line Setting","url":"https://stock-news.laohu8.com/highlight/detail?id=1164145033","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164145033?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:01","pubTimestamp":1787817666,"startTime":"0","endTime":"0","summary":"On August 26, the U.S. Food and Drug Administration (FDA) granted approval to Revolution Medicines for its oral therapy Rasonque (generic name: daraxonrasib), designated for adults with metastatic...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":4,"totalSize":401,"code":"91000000","status":"200"}]}}